查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1356826

產前檢測與新生兒篩檢市場報告：2030 年趨勢、預測與競爭分析

Prenatal Testing & Newborn Screening Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

產前檢測和新生兒篩檢趨勢和預測

至2030年，全球產前檢測和新生兒篩檢市場預計將達到108億美元，2024年至2030年的年複合成長率為12.8%。該市場的主要促進因素是遺傳疾病患病的增加和嬰兒染色體症候群病例的增加。全球產前檢測和新生兒篩檢市場的未來看起來充滿希望，醫院和診斷中心市場也充滿機會。

產前檢測與新生兒篩檢市場洞察

Lucintel 預測，非侵入性檢測預計將在預測期內出現高速成長，因為它們不會對胎兒構成風險，而且流產的可能性較低。

隨著越來越多的患者選擇該設施來做出資訊的決定，預計該醫院將在預測期內實現高速成長。

由於該地區遺傳性疾病病例數量不斷增加以及有利的報銷政策，預計北美地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球產前檢測與新生兒篩檢市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球產前檢測和新生兒篩檢市場趨勢（2018-2023）和預測（2024-2030）
  • 按診斷類型分類的全球產前檢測和新生兒篩檢市場
    • 侵入性的
    • 非侵入性
  • 按技術分類的全球產前檢測和新生兒篩檢市場
    • 篩選技術
    • 診斷技術
  • 按最終用途的全球產前檢測和新生兒篩檢市場
    • 醫院
    • 診斷中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球產前檢測和新生兒篩檢市場（按地區）
  • 北美產前檢測與新生兒篩檢市場
  • 歐洲產前檢測與新生兒篩檢市場
  • 亞太產前檢測與新生兒篩檢市場
  • 其他地區產前檢測及新生兒篩檢市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按診斷類型分類的全球產前檢測和新生兒篩檢市場成長機會
    • 全球產前檢測和新生兒篩檢市場的技術成長機會
    • 全球產前檢測和新生兒篩檢市場成長機會（按最終用途）
    • 全球產前檢測和新生兒篩檢市場按地區成長機會
  • 全球產前檢測和新生兒篩檢市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球產前檢測和新生兒篩檢市場的能力
    • 全球產前檢測和新生兒篩檢市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • PerkinElmer
  • Natera
  • Invitae
  • Centogene
  • Cradle Genomics
  • Hoffmann-La Roche
  • Quest Diagnostics
  • Baebies
  • Ravgen
  • Eurofins Scientific
簡介目錄

Prenatal Testing & Newborn Screening Trends and Forecast

The future of the global prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets. The global prenatal testing & newborn screening market is expected to reach an estimated $10.8 billion by 2030 with a CAGR of 12.8% from 2024 to 2030. The major drivers for this market are growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.

A more than 150-page report is developed to help in your business decisions.

Prenatal Testing & Newborn Screening by Segment

The study includes a forecast for the global prenatal testing & newborn screening by diagnostic type, technology, end use, and region.

Prenatal Testing & Newborn Screening Market by Diagnostic Type [Shipment Analysis by Value from 2018 to 2030]:

  • Invasive
  • Non-Invasive

Prenatal Testing & Newborn Screening Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Screening Technology
  • Diagnostic Technology

Prenatal Testing & Newborn Screening Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Others

Prenatal Testing & Newborn Screening Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Prenatal Testing & Newborn Screening Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies prenatal testing & newborn screening companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prenatal testing & newborn screening companies profiled in this report include-

  • Perkinelmer
  • Natera
  • Invitae
  • Centogene
  • Cradle Genomics
  • Hoffmann-La Roche
  • Quest Diagnostics
  • Baebies
  • Ravgen
  • Eurofins Scientific

Prenatal Testing & Newborn Screening Market Insights

Lucintel forecasts that non-invasive is expected to witness higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.

Hospital is expected to witness higher growth over the forecast perioddue to growing patients preference for this facility to make informed decisions.

North America is expected to witness highest growth over the forecast period due to growing number of genetic disorders cases and presence of favourable reimbursement policy in the region.

Features of the Global Prenatal Testing & Newborn Screening Market

Market Size Estimates: Prenatal testing & newborn screening market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Prenatal testing & newborn screening market size by diagnostic type, technology, end use, and region. in terms of value ($B).

Regional Analysis: Prenatal testing & newborn screening market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic types, technologies, end uses, and region.s for the prenatal testing & newborn screening market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the prenatal testing & newborn screening market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the prenatal testing & newborn screening market size?

Answer: The global prenatal testing & newborn screening market is expected to reach an estimated $10.8 billion by 2030.

Q.2. What is the growth forecast for prenatal testing & newborn screening market?

Answer: The global prenatal testing & newborn screening market is expected to grow with a CAGR of 12.8% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the prenatal testing & newborn screening market?

Answer: The major drivers for this market are growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.

Q.4. What are the major segments for prenatal testing & newborn screening market?

Answer: The future of the prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets.

Q.5. Who are the key prenatal testing & newborn screening market companies?

Answer: Some of the key prenatal testing & newborn screening companies are as follows:

  • PerkinElmer
  • Natera
  • Invitae
  • Centogene
  • Cradle Genomics
  • Hoffmann-La Roche
  • Quest Diagnostics
  • Baebies
  • Ravgen
  • Eurofins Scientific

Q.6. Which prenatal testing & newborn screening market segment will be the largest in future?

Answer: Lucintel forecasts that non-invasive is expected to witness higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.

Q.7. In prenatal testing & newborn screening market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing number of genetic disorders cases and presence of favourable reimbursement policy in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the prenatal testing & newborn screening market by diagnostic type (invasive and non-invasive), technology (screening technology and diagnostic technology), end use (hospitals, diagnostic centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Prenatal Testing & Newborn Screening Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Prenatal Testing & Newborn Screening Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Prenatal Testing & Newborn Screening Market by Diagnostic Type
    • 3.3.1: Invasive
    • 3.3.2: Non-Invasive
  • 3.4: Global Prenatal Testing & Newborn Screening Market by Technology
    • 3.4.1: Screening Technology
    • 3.4.2: Diagnostic Technology
  • 3.5: Global Prenatal Testing & Newborn Screening Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Diagnostic Centers
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Prenatal Testing & Newborn Screening Market by Region
  • 4.2: North American Prenatal Testing & Newborn Screening Market
    • 4.2.2: North American Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
  • 4.3: European Prenatal Testing & Newborn Screening Market
    • 4.3.1: European Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
    • 4.3.2: European Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
  • 4.4: APAC Prenatal Testing & Newborn Screening Market
    • 4.4.1: APAC Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
    • 4.4.2: APAC Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
  • 4.5: ROW Prenatal Testing & Newborn Screening Market
    • 4.5.1: ROW Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
    • 4.5.2: ROW Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Diagnostic Type
    • 6.1.2: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Technology
    • 6.1.3: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by End Use
    • 6.1.4: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Region
  • 6.2: Emerging Trends in the Global Prenatal Testing & Newborn Screening Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Prenatal Testing & Newborn Screening Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Prenatal Testing & Newborn Screening Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: PerkinElmer
  • 7.2: Natera
  • 7.3: Invitae
  • 7.4: Centogene
  • 7.5: Cradle Genomics
  • 7.6: Hoffmann-La Roche
  • 7.7: Quest Diagnostics
  • 7.8: Baebies
  • 7.9: Ravgen
  • 7.10: Eurofins Scientific